LogseqFMS/pages/hls__Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.md

file:: [Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.pdf](../assets/Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.pdf)
file-path:: ../assets/Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.pdf

- an overwhelming majority of the patients are from endemic regions and that providers are familiar with screening for other infectious diseases in this population
  ls-type:: annotation
  hl-page:: 2
  hl-color:: yellow
  id:: 6597dc6f-0e20-475b-91e0-6db05320c6f4
- pre-established wellness labs through which Chagas screening could be conducted in all high-risk individuals
  ls-type:: annotation
  hl-page:: 3
  hl-color:: yellow
  id:: 6597dc80-16db-444c-9d78-a0367a69af5b
- effort to ensure all relatives of positive patients be screened
  ls-type:: annotation
  hl-page:: 3
  hl-color:: yellow
  id:: 6597dcad-dbe9-495f-bd54-a5e75fab31f7
- many aspects of the US efforts to improve care for Chagas disease are similar to those in other non-endemic countries such as Spain or non-endemic regions within Latin America including urban areas
  ls-type:: annotation
  hl-page:: 3
  hl-color:: yellow
  id:: 6597dcc6-5622-4080-9a39-016d74731f49